How are you using ArteraAI in 2026 for intermediate risk patients?

Personally, I have not used ArteraAI to guide treatment decisions. None of the advanced prognostic tools of this nature have been prospectively evaluated. Consequently, I am reluctant to use them to influence treatment decisions at this time. The post hoc meta-analyses are promising, and hopefully, ...